Medical devices, healthcare technology and the business of care
510(k) clearance · K260008

Deterioration Index Version 2

Epic Systems Corporation · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONK260008

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 18, 2026 for Deterioration Index Version 2, submitted by Epic Systems Corporation under 510(k) number K260008. The device is clinical decision support software that calculates a deterioration risk score for adults aged 18 and older in inpatient, observation, or emergency department observation settings, and it must be used with the Epic electronic health record. It is regulated as an adjunctive predictive cardiovascular indicator under 21 CFR 870.2210, Class II, product code QNL.

The submission cites eCARTv5 Clinical Deterioration Suite (K233253) as predicate. The summary describes differences including a broader composite outcome, a 72-hour rather than 24-hour mortality horizon, scheduled rather than documentation-triggered scoring, and additional inputs. A retrospective validation across three U.S. sites is reported, but the available excerpts do not give complete performance figures or the full intended-use statement, so those details remain unverified here. SESE denotes clearance, not PMA approval.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 18, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260008
Regulatory pathway
510(k) premarket notification
Product code
QNL
Decision code
SESE
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Medium-Term Adjunctive Predictive Cardiovascular Indicator.

Product code
QNL
FDA device class
2

FDA decision timeline

  1. K260008 received

    Application receipt date recorded by FDA.

  2. K260008 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Epic Systems Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Verona, WI

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records